Related by context. All words. (Click for frequent words.) 79 thrombocytopenia 77 febrile neutropenia 74 leukopenia 72 Neutropenia 69 lymphopenia 69 leucopenia 68 hematologic toxicity 67 peripheral sensory neuropathy 66 myelosuppression 65 hematologic adverse 65 neutropaenia 65 severe neutropenia 64 infusion reactions 63 hypophosphatemia 63 toxicities 63 mucositis 63 events AEs 63 gastrointestinal toxicities 62 neutropenia thrombocytopenia 62 Adverse events 62 laboratory abnormalities 62 neutropenia dehydration dyspnea 61 neutropenia anemia 61 AEs 61 treatment emergent adverse 61 lopinavir r arm 60 neutropenic 60 anemia neutropenia 60 discontinuations due 60 non hematological toxicities 60 hematological adverse 60 fatigue asthenia 60 peripheral edema 60 incidence ≥ 60 nasopharyngitis 60 FluCAM arm 60 thrombocytopenia neutropenia 59 pyrexia 59 hypokalemia 59 mitoxantrone 59 hypomagnesemia 59 discontinuations 59 hypotension 59 alpha interferons 59 stomatitis 59 patients receiving ERBITUX 59 DOXIL 59 hypersensitivity reactions 59 pyrexia mucositis sepsis febrile 59 hematologic toxicities 58 thromboembolic events 58 anemia nausea 58 thrombocytopenia anemia 58 ALT flares 58 arthralgia 58 Febrile neutropenia 58 nephrotoxicity 58 Dermatologic toxicities 58 hypocalcemia 57 dose limiting toxicities 57 posaconazole 57 5-FU/LV 57 acneform rash 57 cytopenias 57 neutropenia febrile neutropenia 57 Toxicities 57 â ‰ ¥ 57 endophthalmitis 57 bone marrow suppression 57 diarrhea nausea vomiting 57 Fludara 57 corticosteroid therapy 57 asthenia 56 renal insufficiency 56 hematological toxicity 56 TORISEL 56 comparator arm 56 chlorambucil 56 neutropenic fever 56 adverse reactions incidence 56 peripheral neuropathy 56 cutaneous squamous cell carcinoma 56 placebo dexamethasone 56 candidemia 56 pancytopenia 56 neutrophil count 56 mycophenolate mofetil 56 FOLFOX 56 APTIVUS r 56 voriconazole 56 neutrophil counts 56 hepatotoxicity 56 atazanavir 56 recurrent VTE 56 headache abdominal pain 56 TMP SMX 56 PREZISTA r 56 hypercalcemia 56 gastrointestinal perforation 56 virologic failure 56 FOLFOX4 55 Peg IFN 55 nausea diarrhea 55 receiving VELCADE 55 QTc prolongation 55 FOLFIRI 55 ocular adverse 55 REYATAZ r arm 55 fatigue diarrhea nausea 55 nausea fatigue 55 hallucinations dyskinesia 55 dermatologic toxicities 55 vandetanib 55 limiting toxicity 55 vWD 55 Pred Forte 55 ATACAND 55 diarrhea nausea fatigue 55 Infusion Reactions Severe 55 Elitek 55 FOLPI 55 myalgia arthralgia 55 hematological toxicities 55 hypersensitivity reaction 55 transaminase elevations 55 cardiac toxicity 55 azathioprine 55 severe hypersensitivity reactions 55 lopinavir r 55 fluorouracil 55 hyperkalemia 55 thrombotic events 55 receiving VICTRELIS 55 delayed CINV 55 sensory neuropathy 55 SAEs 55 NEUPOGEN 54 heparin induced thrombocytopenia 54 non metastatic osteosarcoma 54 virological failure 54 Thrombocytopenia 54 intracranial hemorrhage ICH 54 ribavirin therapy 54 ceftriaxone 54 mg BID 54 mucosal inflammation 54 anemia hemoglobin 54 DLTs 54 tumor lysis syndrome 54 myopathy rhabdomyolysis 54 Hematologic 54 4mg/kg 54 dyspnea 54 LPV r 54 BARACLUDE ® 54 histologic subtype 54 pruritis 54 Navelbine 54 neutropenic patients 54 Discontinuations 54 danazol 54 levofloxacin 54 cabazitaxel 54 headache nasopharyngitis 54 ACTEMRA 54 HBeAg negative 54 ZYVOX 54 cisplatin chemotherapy 54 Myelosuppression 54 mg/m2 dose 54 events SAEs 54 chills fever headache 54 piperacillin tazobactam 54 HBeAg negative patients 54 renal toxicity 54 Peripheral edema 54 tipranavir ritonavir 54 Angioedema 54 sunitinib 54 RBC transfusions 54 dasatinib 54 Ribavirin causes 54 myalgia 54 hemorrhagic cystitis 54 FOLFIRI alone 54 tolvaptan 54 HbA 1c levels 53 oral vancomycin 53 amoxicillin clavulanate 53 imipenem 53 achieved ACR# 53 lactic acidosis 53 Flu Cy 53 peripheral neuropathy CPN 53 spinal cord compression 53 μg dose 53 mouth sores 53 PROCRIT 53 radiation dermatitis 53 TEAEs 53 MALT lymphoma 53 constipation nausea 53 TELINTRA 53 G CSF 53 receiving ISENTRESS 53 esophagitis 53 severe oral mucositis 53 immunosuppressive agents 53 CINV 53 gout flares 53 vinorelbine 53 del 5q MDS 53 REMICADE ® 53 Serious adverse reactions 53 biologic DMARD 53 arterial thromboembolic events 53 trastuzumab 53 virologic breakthrough 53 chronic GVHD 53 haematologic 53 evaluable 53 IXEMPRA 53 log# copies mL 53 extrapyramidal symptoms 53 essential thrombocythemia 53 myalgias 53 alanine aminotransferase 53 metastatic lung cancer 53 arthralgias 53 metastatic GIST 53 pericardial effusion 53 ABC/3TC 53 monotherapy 53 lamivudine 53 CMV infection 53 ug dose 53 concomitant medications 53 recurrent glioblastoma multiforme 53 recurrent genital herpes 53 Zometa hazard 53 adriamycin 53 TNF antagonist 53 invasive fungal infections 53 pheochromocytoma 53 peginterferon alfa 2b 53 DMARDS 53 hematologic adverse reactions 53 HBeAg seroconversion 53 etravirine 53 alfa 2a 53 amphotericin B 53 nasopharyngitis headache 53 chemotherapy induced neutropenia 53 events TEAEs 53 dasatinib Sprycel ® 53 haematological toxicity 53 anemia leukopenia 53 zidovudine lamivudine 53 immune thrombocytopenic purpura ITP 53 darunavir r 53 ALT elevations 52 refractory NSCLC 52 superficial edema 52 post herpetic neuralgia PHN 52 ARCOXIA 52 acute GvHD 52 mg dose 52 pegylated liposomal doxorubicin 52 doxorubicin docetaxel 52 Amgen Neulasta ® 52 daunorubicin 52 VELCADE melphalan 52 topotecan 52 REVLIMID ® 52 #mg BID [001] 52 aprepitant 52 panitumumab Vectibix 52 headache diarrhea nausea 52 vaccine serotypes 52 recurrent UTI 52 bortezomib 52 headache nausea diarrhea 52 ZIAGEN 52 myelosuppressive chemotherapy 52 mg/m2 52 PREZISTA rtv 52 basal cell carcinoma BCC 52 mg kg dose 52 rizatriptan 52 decitabine 52 CMV disease 52 nausea vomiting headache 52 hepatic failure 52 EXJADE 52 dizziness nausea diarrhea 52 oxycodone CR 52 external genital lesions 52 experienced hypomagnesemia 52 infection sinusitis 52 refractory gout 52 Lupus nephritis 52 unresectable HCC 52 clodronate 52 Lactic acidosis 52 KRAS mutant tumors 52 GEMZAR 52 neuroleptic malignant syndrome 52 mcg albinterferon alfa 2b 52 pruritus 52 P = .# 52 Tindamax R 52 severe hypoglycemic 52 paresthesias 52 idiopathic thrombocytopenic purpura 52 idarubicin 52 abacavir lamivudine 52 NATRECOR R 52 KETEK 52 LEXIVA 52 receiving prophylactic anticoagulation 52 RBC transfusion 52 grade cervical intraepithelial 52 tigecycline 52 hemorrhagic complications 52 transaminase elevation 52 receiving XGEVA 52 undetectable viral loads 52 % CI #.#-#.# [007] 52 docetaxel Taxotere 52 Treatment discontinuations due 52 venous thromboembolic events 52 LEXIVA r 52 Neulasta ® 52 hepatic adverse 52 ribavirin RBV 52 leukocytosis 52 LOVENOX R 52 DOXIL ® 52 doxorubicin cyclophosphamide 52 adverse cytogenetics 52 elevated ALT 52 fatigue nausea 52 cerebrovascular events 52 anemia 52 Aptivus ® 52 mcg kg REBETOL 52 calcineurin inhibitors 52 AVELOX 52 palifermin 52 plus dexamethasone 52 mRCC 52 lupus nephritis 52 peginterferon alfa 52 palonosetron 52 stage IIIB 52 hepatorenal syndrome 52 hemoptysis 52 Hodgkin lymphoma NHL 52 Hypersensitivity reactions 51 lymphocytosis 51 nonhematologic adverse reactions 51 hepatic dysfunction 51 HBeAg positive patients 51 dermatologic reactions 51 mg QD 51 peginterferon 51 anaphylactoid reactions 51 amiodarone 51 interferon alfa 51 MYCAMINE 51 plus methotrexate 51 NRTIs 51 antiemetics 51 hypomethylating agents 51 VFEND 51 pneumonitis 51 peg IFN 51 generalized edema 51 diarrhea nausea 51 cytogenetic responses 51 BARACLUDE 51 cervical intraepithelial neoplasia 51 advanced adenomas 51 ifosfamide 51 non squamous NSCLC 51 docetaxel chemotherapy 51 Taxotere R 51 INVANZ 51 VAPRISOL 51 SPRYCEL ® 51 hyperphenylalaninemia HPA due 51 ARCALYST ® 51 NOLVADEX 51 highly emetogenic 51 cyclophosphamide methotrexate 51 endometrial hyperplasia 51 INTELENCE 51 CD4 + cell 51 pT3 51 octreotide LAR 51 eribulin 51 angioedema 51 standard chemotherapy regimen 51 tipranavir r 51 aspartate aminotransferase 51 adverse reactions irrespective 51 linezolid 51 opportunistic infections 51 diarrhea vomiting nausea 51 idraparinux 51 mcg QD 51 ovarian hyperstimulation syndrome OHSS 51 COPD exacerbation 51 amprenavir 51 solar keratoses 51 azacitidine 51 pamidronate 51 #mg/m# [001] 51 Taxotere ® 51 efalizumab 51 chronic HCV infection 51 imatinib 51 anakinra 51 fluvastatin 51 HIV RNA 51 Cutaneous T 51 anthracycline taxane 51 Doxil ® 51 FOLFOX4 alone 51 interferon alfa 2a 51 abdominal pain diarrhea 51 INVEGA ® 51 precancerous cervical lesions 51 hypoglycemic events 51 postoperative nausea 51 elotuzumab 51 transaminases 51 fatigue abdominal pain 51 mcg mL 51 mcg BID 51 chills fatigue 51 AGILECT ® 51 INFERGEN 51 Renal impairment 51 vancomycin 51 Noxafil 51 rituximab 51 ritonavir boosted 51 Myelodysplastic Syndrome MDS 51 adverse reactions occurring 51 Q2W 51 angiotensin converting enzyme inhibitors 51 systemic absorption 51 teriflunomide 51 REYATAZ r 51 invasive candidiasis 51 TAXOTERE ® 51 PEGylated anti 51 Dasatinib 51 bacteremia 51 myelodysplastic syndromes MDS 51 docetaxel Taxotere ® 51 adverse reactions ≥ 51 GVHD 51 agranulocytosis 51 PEG Interferon alfa 51 thromboembolic 51 Median survival 51 prednisone prednisolone 51 adverse reactions observed 51 CIMZIA 51 asthenia pain 51 CR nPR 51 erlotinib Tarceva ® 51 nadolol 51 liver decompensation 51 cytotoxic chemotherapy 51 definite stent thrombosis 51 pCR 51 CTAP# Capsules 51 prolonged QT interval 51 ALT elevation 51 certolizumab 51 Stent thrombosis 51 fevers chills 51 platelet counts 51 efavirenz Sustiva 51 pegfilgrastim 51 somnolence fatigue 51 EFFEXOR XR 51 dexamethasone Decadron 51 Pharmacokinetics PK 51 mcg kg 51 thrombocytopenic 51 treatment emergent AEs 51 myelofibrosis polycythemia vera 50 angioneurotic edema 50 Vfend 50 rilpivirine 50 severe renal impairment 50 Torsades de Pointes 50 adefovir 50 adalimumab 50 orthostatic hypotension 50 tacrolimus 50 hydroxyurea 50 ® lenalidomide 50 pathologic fractures 50 lichen planus 50 Serious ocular 50 tipranavir 50 CIMZIA TM certolizumab pegol 50 REYATAZ ® 50 ARIXTRA 50 QTcF 50 recurrent venous thromboembolism 50 sarcomatoid 50 Viread Emtriva 50 CIMZIA TM 50 Cimzia TM 50 rash desquamation 50 indinavir 50 hemolytic anemia 50 plasma uric acid 50 peripheral neuropathy CIPN 50 metastatic renal cell carcinoma 50 metastatic malignant melanoma 50 5FU 50 Treatment emergent adverse 50 eosinophilic pneumonia 50 REYATAZ 50 immunocompetent patients 50 enoxaparin 50 epithelial tumors 50 gemcitabine carboplatin 50 mg m 50 dalteparin 50 locoregional 50 dose cytarabine 50 interstitial lung disease 50 invasive aspergillosis 50 Kivexa 50 EGFR inhibitors 50 etoposide 50 solifenacin 50 PREMPRO 50 OADs 50 distant metastasis 50 hypereosinophilic syndrome 50 reinfarction 50 visilizumab 50 bendamustine 50 HBeAg positive 50 PROMACTA 50 median PFS 50 NNRTIs 50 complete remissions 50 Paraplatin ® 50 virologic response 50 romiplostim 50 intravenous bisphosphonates 50 TAXOTERE R 50 TDF FTC 50 extrapyramidal disorder 50 PEGINTRON TM 50 HES CEL 50 relapsed MM 50 Navelbine ® 50 Adalimumab 50 Myelofibrosis 50 anterior uveitis 50 intermittent dosing 50 serum potassium 50 included neutropenia anemia 50 tumor recurrence 50 GISTs 50 CsA 50 Pegylated Interferon 50 superficial bladder cancer 50 IIIa inhibitor 50 hepatitis C genotype 50 dacarbazine 50 ara C 50 tirofiban 50 hyperbilirubinemia 50 OHR/AVR# 50 nephrotoxic 50 Kepivance 50 rFVIIa 50 COMBIVIR 50 % CI #.#-#.# [003] 50 flutamide 50 AZT zidovudine Retrovir 50 thromboembolism 50 VIIBRYD 50 hypercholesterolaemia 50 capillary leak 50 infusional 50 mg m² 50 hypoglycaemia 50 FROVA 50 imatinib resistant 50 distant metastases 50 SUSTIVA 50 aldosterone antagonist 50 tocilizumab 50 hypoglycaemic episodes 50 forodesine 50 PAOD 50 Tavocept 50 diarrhea headache nausea 50 Folfox 50 oxcarbazepine 50 denileukin diftitox 50 lamotrigine 50 Coadministration 50 tenofovir emtricitabine 50 diarrhea abdominal pain 50 basiliximab 50 ORENCIA 50 Durezol 50 insulin detemir 50 VaD 50 enterocolitis 50 benazepril 50 edema peripheral 50 cells/mm3 50 raltegravir 50 purpura ITP 50 genotypic resistance 50 peginterferon alfa 2a 50 vaccinees 50 sarcomas 50 rhinorrhea 50 exacerbations 50 acarbose 50 Peginterferon alfa 2b 50 deep venous thromboses 50 Known hypersensitivity 50 paclitaxel carboplatin 50 deletion 5q 50 receiving INTRON 50 Serious Adverse Events 50 cidofovir 50 Dacogen injection 50 zoledronic acid 50 ULORIC 50 low dose cytarabine 50 hematologic disorders 50 EGFRIs 50 abdominal pain headache 50 oblimersen 50 S. aureus infections 50 mitoxantrone plus 50 interferon gamma 1b 50 tapentadol ER 50 serotonergic drugs 50 gemcitabine Gemzar ® 50 myelodysplastic myeloproliferative diseases 49 valacyclovir 49 Hypotension 49 BENICAR HCT 49 pulmonary exacerbations 49 EBRT 49 severe rotavirus gastroenteritis 49 ipsilateral stroke 49 SHPT 49 8mg/kg 49 VEGF inhibitors 49 sulfasalazine 49 myelofibrosis 49 pegylated interferon alpha 49 severe hypoglycemia 49 mucocutaneous reactions 49 standard chemotherapy regimens 49 creatinine clearance 49 PREZISTA ritonavir 49 nevirapine Viramune 49 tamoxifen Nolvadex ® 49 follicular lymphoma 49 acute gout flares 49 SMZ TMP 49 CHOP chemotherapy 49 ARICEPT 49 nadroparin 49 Telithromycin 49 CCyR 49 AGILECT R 49 renal impairment 49 pharyngolaryngeal pain 49 malignancy HCM 49 lymphoid blast 49 Arixtra 49 adjunctive ABILIFY 49 thalidomide Thalomid 49 intravenous vancomycin 49 nucleoside naive 49 mycophenolate mofetil MMF 49 hyperglycemia 49 Nausea vomiting 49 relapsed multiple myeloma 49 TYSABRI treated 49 aspartate aminotransferase AST 49 gastrointestinal stromal tumor 49 gastrointestinal stromal tumor GIST 49 Kidney toxicity nephrotoxicity 49 electrolyte abnormalities 49 chronic lymphocytic leukemia CLL 49 mg ustekinumab 49 LYSTEDA 49 induce orthostatic hypotension 49 triamcinolone 49 salmeterol HFA MDI 49 cetuximab 49 phenytoin 49 fondaparinux 49 lopinavir ritonavir Kaletra 49 RLAI 49 Telintra 49 bone metastases 49 HCV genotype 1 49 oral levofloxacin 49 heavily pretreated 49 Exacerbations 49 zolmitriptan 49 anagrelide 49 nitrofurantoin 49 iniparib BSI 49 absolute neutrophil count 49 cisplatin gemcitabine 49 O PPDS 49 Gleevec resistant 49 evaluable subjects 49 sustained virologic response 49 Pruvel 49 cryptococcal meningitis 49 adrenal suppression 49 recurrent DVT 49 nicardipine 49 mcg doses 49 anthracycline containing 49 CANCIDAS 49 #mg/m# [002] 49 DFMO 49 immunomodulatory therapy 49 infliximab monotherapy 49 infection nasopharyngitis 49 severe exacerbations 49 Atacand 49 Erythropoietic therapies may 49 aminotransferase elevations greater 49 ISENTRESS 49 asthma exacerbation 49 headache chills 49 ONTAK 49 #mg BID [003] 49 azoles 49 sirolimus 49 unknown etiology 49 VIDAZA 49 nausea somnolence 49 non splenectomized 49 atazanavir ritonavir 49 bevacizumab Avastin 49 ZOMIG 49 Torisel 49 intermittent claudication 49 Vaprisol 49 serum creatinine levels 49 ritonavir boosted lopinavir 49 relapsed SCLC 49 thrombophlebitis 49 erythema redness 49 secondary hyperparathyroidism 49 HBeAg 49 Velcade bortezomib 49 events thrombocytopenia neutropenia 49 abatacept 49 MULTAQ 49 adefovir treated 49 DAPT 49 etanercept 49 oral antidiabetic medication 49 lispro 49 COPD exacerbations 49 Cytoxan 49 rotavirus gastroenteritis 49 immunosuppression 49 SGPT 49 ertapenem 49 nonmetastatic 49 skin rash 49 moderately emetogenic 49 sorafenib Nexavar 49 treatment naive genotype 49 pegylated interferon alfa 49 Eltrombopag 49 Follicular Lymphoma 49 cIAI 49 metastatic RCC 49 baseline HbA1c 49 nephrotoxic drugs 49 androgen deprivation 49 adverse reactions 49 oxymorphone ER 49 lopinavir 49 hematologic abnormalities 49 imatinib Gleevec ® 49 Amigal 49 plus ribavirin 49 PegIFN RBV 49 Angiomax monotherapy 49 leukemia AML 49 baminercept 49 ketoconazole 49 Acute myeloid leukemia 49 5 Fluorouracil 49 epistaxis 49 leukemia ALL 49 TRIZIVIR 49 dopaminergic therapy 49 chronic HCV 49 alemtuzumab treated 49 nephropathy 49 leukemia CLL 49 antiarrhythmic drugs 49 achieved PASI 49 thrombocytosis 49 alkylating agent 49 mg/m2/day 49 β blockers 49 interferon alfa 2b 49 dexamethasone 49 RISPERDAL ® 49 gastric ulcers 49 x ULN 49 pyrazinamide 49 Discontinuations due 49 delayed onset CINV 49 myelosuppressive 49 β blocker 49 bone marrow reticulin deposition 49 INTRON 49 NOXAFIL 49 Epratuzumab 48 Median PFS 48 antiretroviral naive 48 desvenlafaxine succinate 48 urticaria hives 48 PEG INTRON 48 urinary retention 48 haloperidol Haldol 48 neurologic symptoms 48 DETROL LA 48 prior chemotherapy regimens 48 immunosuppressives 48 elevated transaminases 48 lenalidomide dexamethasone 48 Chronic Lymphocytic Leukemia CLL 48 certolizumab pegol 48 tamsulosin 48 mycosis fungoides 48 primidone 48 liver transaminases 48 p = #.# [003] 48 imatinib mesylate 48 Revlimid lenalidomide 48 lumiracoxib 48 NOMID 48 FUSILEV enhances 48 thrombocytopenic patients 48 plus OBT 48 CAELYX 48 MADRS score 48 fatigue nausea vomiting 48 aldosterone antagonists 48 cisplatin 48 PRADAXA 48 Relapsed Refractory 48 nausea diarrhea constipation 48 dapsone 48 carbamazepine Tegretol 48 CIMZIA ™ 48 adjunctive placebo 48 vincristine doxorubicin 48 glycated hemoglobin levels 48 cholecystitis 48 diarrhea nausea abdominal pain 48 HMG CoA reductase inhibitors 48 systemic corticosteroid 48 FluCAM 48 #mg/day [001] 48 unfavorable cytogenetics 48 Hepatotoxicity 48 headache nausea fatigue 48 pyridostigmine 48 coinfected patients 48 tardive dyskinesia TD 48 acute GVHD 48 Dose adjustments 48 fosamprenavir 48 GvHD 48 dexrazoxane 48 thyrotoxicosis 48 Novantrone 48 torsade de pointes 48 Calcineurin inhibitors 48 cell lymphoma CTCL 48 cSSSI 48 nucleoside analogues 48 grade glioma 48 isoproterenol 48 log# reduction 48 antimicrobial prophylaxis 48 LAMICTAL 48 esophageal candidiasis 48 mg q#h 48 canakinumab 48 ARCALYST 48 Adjuvant chemotherapy 48 hepatic toxicity 48 tumoral 48 potentially hepatotoxic 48 chronic HBV infection 48 divalproex sodium 48 cinacalcet 48 fulminant hepatitis 48 recurrent NSCLC 48 Secondary endpoints 48 Mg Uk 48 Peginterferon Alfa 2a 48 DMARD 48 serum phosphate levels 48 insomnia somnolence 48 symptomatic pulmonary embolism 48 hepatic encephalopathy HE 48 gastrointestinal toxicity 48 gemcitabine 48 antiandrogen 48 cardiotoxicity 48 baseline CD4 48 ritonavir boosted atazanavir 48 cetuximab Erbitux ® 48 Forodesine HCl 48 IGIV 48 SJIA 48 gout flare 48 post herpetic neuralgia 48 bevacizumab Avastin ® 48 metastatic neuroendocrine tumors 48 metastatic malignant 48 relapsing multiple sclerosis 48 lymphocyte count 48 mg tid 48 Pemetrexed 48 bilirubin 48 Host Disease 48 pruritus itching 48 trans retinoic acid 48 asthenia fatigue 48 filgrastim 48 actinic keratoses 48 pegylated interferon alfa 2a 48 disease progression 48 nausea vomiting diarrhea 48 ZOSTAVAX 48 serum HBV DNA 48 fever chills 48 interferon alpha 48 febuxostat 48 concomitant AEDs 48 liver toxicity 48 protease inhibitor PI 48 fallopian tube carcinoma 48 antiretroviral naïve 48 seminoma 48 fluid overload 48 Candida infection 48 FASLODEX 48 Viread Emtriva Sustiva 48 REMINYL ® 48 Chemotherapy induced 48 LVEF 48 SREs 48 stage IIIb IV 48 3TC lamivudine Epivir 48 NNT = 48 symptomatic hypotension 48 argatroban 48 syncope fainting 48 #mg QD [001] 48 syncopal 48 eculizumab 48 Fludarabine 48 Certolizumab 48 serum calcium levels 48 Vidofludimus 48 pneumococcal pneumonia 48 Gleevec imatinib mesylate